Avidity Biosciences
RNAM
#1855
Rank
C$15.37 B
Marketcap
C$99.50
Share price
0.00%
Change (1 day)
129.92%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: C$15.37 Billion

As of April 2026 Avidity Biosciences has a market cap of C$15.37 Billion. This makes Avidity Biosciences the world's 1855th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026C$15.37 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$209.86 B 1,265.31%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$148.47 B 865.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.91 B-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$7.72 B-49.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.21 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$14.93 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.56 B-70.29%๐Ÿ‡บ๐Ÿ‡ธ USA